Literature DB >> 19017661

Osteosarcoma arising in a long-standing uterine leiomyoma: a case report and literature review.

Ren Ching Wang1, Mei Ching Wen, John Wang, Shin Chu Ho, Yee Jee Jan.   

Abstract

The authors present the first case of a pure osteosarcoma arising in a long-standing uterine leiomyoma along with a literature review of all heterologous sarcomas arising in uterine leiomyoma. Most cases present with abnormal vaginal bleeding and symptoms related to a rapidly enlarged pelvic mass in postmenopausal women with a long-standing history of uterine leiomyoma. The histological finding of the case in this study revealed a relatively well-circumscribed tumor with a peripheral ring of leiomyoma and a central osteosarcoma. The case in this study further supported a possible pathogenesis involving the p53 gene. The prognosis may be better with low-stage tumor; however, cases with advanced stages, larger tumor size at presentation, and histological type of epithelioid angiosarcoma had poorer prognosis despite aggressive therapy.

Entities:  

Mesh:

Year:  2008        PMID: 19017661     DOI: 10.1177/1066896908327037

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  3 in total

1.  Silencing of VEGF inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via VEGF/PI3K/AKT signaling pathway.

Authors:  Ningning Peng; Shuming Gao; Xu Guo; Guangya Wang; Cai Cheng; Min Li; Kehun Liu
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

2.  Primary uterine osteosarcoma presenting synchronously with bilateral breast carcinomas.

Authors:  George Powell; Laura Barth; Richard Todd; Raji Ganesan
Journal:  BMJ Case Rep       Date:  2014-06-04

Review 3.  An unusual case of an osteosarcoma arising in a leiomyoma of the uterus.

Authors:  Mehmet Kefeli; Sancar Baris; Oguz Aydin; Levent Yıldız; Seda Yamak; Bedri Kandemir
Journal:  Ann Saudi Med       Date:  2012 Sep-Oct       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.